Kerr Douglas's Form 4 filing
Dyne Therapeutics, Inc. (DYN) · filed Sep 8, 2025
- Accession no.
- 0000950170-25-113538
- Filed
- Sep 8, 2025
- Trade date
- Sep 4-5, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $58.8K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Kerr DouglasCIK 0001814189 | Officer (Chief Medical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 4, 2025 | Common Stock | SSaleDisposed | −3,552 | $13.27 | −$47,135.04 | 89,263 | Direct | |
| Sep 5, 2025 | Common Stock | SSaleDisposed | −873 | $13.41 | −$11,706.93 | 88,390 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.